EGR-1-IN-1
Based on 3 publication(s) in Google Scholar
EGR-1-IN-1 is a EGR-1 inhibitor with an IC50 of 1.86 μM. EGR-1-IN-1 binds to the zinc finger DNA-binding domain of EGR-1 and promotes the dissociation of the EGR-1-DNA complex. EGR-1-IN-1 reduces the mRNA expression levels of EGR-1-regulated inflammatory genes induced by TNFα. EGR-1-IN-1 alleviates atopic dermatitis-like lesions in the ear skin of mice. EGR-1-IN-1 serves as a lead compound for the development of targeted compounds for inflammatory skin diseases. EGR-1-IN-1 can be used in studies related to atopic dermatitis.
For research use only. We do not sell to patients.
- Purity: 99.07%
- CAS No.: 3077196-25-6
- Formula: C17H13N5O2S
- Molecular Weight:351.38
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Bioactive Compound Library Max
HY-L181
-
Bioactive Compound Library
HY-L001
-
Epigenetics Compound Library
HY-L005
-
Immunology/Inflammation Compound Library
HY-L007
-
Differentiation Inducing Compound Library
HY-L038
-
Reprogramming Compound Library
HY-L039
-
Anti-Blood Cancer Compound Library
HY-L079
-
Angiogenesis-Related Compound Library
HY-L088
-
Transcription Factor-Targeted Library
HY-L090
-
Cancer Stem Cells Compound Library
HY-L135
-
Cytokine Inhibitors Library
HY-L161
-
Anti-Hematopathy Compound Library
HY-L171
-
Radioprotector Library
HY-L178
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
HY-L199
-
Methylation Compound Library
HY-L203
-
High-Throughput Bioactive Compound Library
HY-L205
-
Anti-Rheumatic Arthritis Compound Library
HY-L210
-
Posttranslational Modification Library
HY-L226
Publications Citing Use of MedChemExpress (MCE) EGR-1-IN-1
More
Customer Validation & Images
-
WB
-
Flow Cytometry
-
Bio/Physico-chemical Assay
-
Bio/Physico-chemical Assay
-
Cell Proliferation/Viability Assay
All DNA Methyltransferase Isoforms
More
Biological Activity
|
13030 1.86 μM (IC50) |
EGR-1-IN-1 (IT25) potently inhibits the DNA-binding activity of human EGR-1, with an IC50 of 1.86 μM in in vitro biochemical assays, and achieves an inhibition rate of 76.1% at a concentration of 50 μM[1].
EGR-1-IN-1 (0-5 μM; 30 min pre-incubation, followed by 1 h TNFα stimulation) inhibits TNFα-induced formation of EGR-1-DNA complexes in human HaCaT keratinocytes[1].
EGR-1-IN-1 (0-5 μM; 30 min pre-incubation, followed by 12 h TNFα stimulation) reduces the mRNA expression of TNFα-induced, EGR-1-regulated inflammatory genes in human HaCaT keratinocytes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human HaCaT keratinocytes
-
Concentration:0, 1, 5 μM
-
Incubation Time:30 min pre-incubation, followed by 12 h TNFα stimulation
-
Result:Dose-dependently reduced TNFα-induced mRNA expression of multiple EGR-1-regulated inflammatory genes, including TSLP, IL17, IL4, IL13, IL23, IL33, IL1β, IL6, CCL2, CCL5, and Artemin.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (male, 6-8-week-old, DNCB-induced atopic dermatitis)[1]
-
Dosage:0.1%
-
Administration:topical; once daily five times weekly; 14 days
-
Result:Considerably improved gross ear skin lesions.
Effectively reduced DNCB-induced epidermal and dermal thickness.
Reduced infiltration of MPO-positive neutrophils, F4/80-positive macrophages, CD3ε-positive Th subsets, and toluidine blue-stained mast cells.
Reduced TSLP expression in the epidermal layer.
Substantially reduced sensory nerve density and intraepidermal innervation at the epidermal-dermal interface.
Chemical Information
-
CAS No. 3077196-25-6
-
Appearance Solid
-
Molecular Weight 351.38
-
Formula C17H13N5O2S
-
Color Light yellow to orange
-
SMILES
COC1=CC2=C(/C(C(N2)=O)=N/NC(NC3=CC=C(C=C3)C#N)=S)C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Adv Sci (Weinh)
AXL Promotes Ischemic Myelin Repair Through Alleviating Myelin Debris Deposition and Lipid Droplets Accumulation. [Abstract]2026 Feb;13(10):e17825. PMID: 41524160
EGR-1-IN-1 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2026 Feb;13(10):e17825. [Abstract]
EGR-1-IN-1 (5 µM) decreased the expression of SMPD1 in Cre- microglia while not in Cre+ microglia after OAM.
EGR-1-IN-1 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2026 Feb;13(10):e17825. [Abstract]
EGR-1-IN-1 (5 µM) increased the BODIPY+ lipid droplets in Cre- microglia after OAM for 6 h.
EGR-1-IN-1 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2026 Feb;13(10):e17825. [Abstract]
EGR-1-IN-1 (5 µM) significantly reduced EGR1 binding to Site-1 and Site-2 regions of the SMPD1 promoter in BV2 cells under OAM conditions.
EGR-1-IN-1 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2026 Feb;13(10):e17825. [Abstract]
EGR-1-IN-1 (5 µM) significantly increased LDs formation in primary microglia in vitro.
-
Am J Chin Med
Andrographolide Suppresses Head and Neck Squamous Cell Carcinoma Progression via EGR1-ACSL4 Axis-Mediated Ferroptosis. [Abstract]2026;54(4):1309-1330. PMID: 42252950 -
Cell Signal
GPR91 mediates low shear stress-induced endothelial ferroptosis via EGR1-dependent GPX4 repression. [Abstract]2025 Sep 10:136:112127. PMID: 40939914
EGR-1-IN-1 purchased from MedChemExpress. Usage Cited in: Cell Signal. 2025 Sep 10:136:112127. [Abstract]
EGR-1-IN-1 (2 μM; 1 h) partially restored viability of HUVECs treated with Erastin.
Solvent & Solubility
DMSO : 1 mg/mL (2.85 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Acetone : < 1 mg/mL (insoluble)
THF : < 1 mg/mL (insoluble)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (279 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.8459 mL | 14.2296 mL | 28.4592 mL | 71.1480 mL |
EGR-1-IN-1 Related Classifications
HY-163731 Related Classifications
Powered by Bioz